Cosalane Analogs with Enhanced Potencies as Inhibitors of HIV-1 Protease and Integrase
摘要:
Several new analogues of the novel anti-HIV agent cosalane have been synthesized and evaluated as inhibitors of HIV-1 integrase and protease, HIV-1 replication, HIV-1 and HIV-2 cytopathicity, HIV-1- and HIV-2-mediated syncytium formation, and cytopathicity of a variety of human pathogenic viruses. The congeners displayed enhanced potencies relative to cosalane itself as inhibitors of HIV-1 integrase and protease. The two most potent analogues against HIV-1 integrase displayed IC50 values of 2.2 mu M, while the three most potent compounds against HIV-1 protease had IC50 values in the 0.35-0.39 mu M range. In addition to its activity against HIV-1 and HIV-2 cytopathicity, cosalane inhibited the cytopathic effects of herpes simplex virus-1, herpes simplex virus-2, and human cytomegalovirus at concentrations that were well below the cytotoxic concentrations. Potentially useful antiviral activities were also revealed for some of the new cosalane congeners against influenza virus, Junin virus, and Tacaribe virus.
Comparative studies of ‘bile salts’. 6. Partial synthesis of coprostanic acid, a ‘stem acid’ of primitive bile salts
作者:R. J. Bridgwater、G. A. D. Haslewood
DOI:10.1042/bj0520588
日期:1952.12.1
Steroidal triphenyl phosphonium salts, versatile intermediates for side chain modifications
作者:J.E. Herz、Sergio Cruz Montalvo
DOI:10.1016/0039-128x(71)90080-8
日期:1971.6
Cosalane Analogs with Enhanced Potencies as Inhibitors of HIV-1 Protease and Integrase
作者:Mark Cushman、W. Marek Golebiewski、Yves Pommier、Abhijit Mazunder、Diane Reymen、Erik De Clercq、Lisa Grahm、William G. Rice
DOI:10.1021/jm00003a007
日期:1995.2
Several new analogues of the novel anti-HIV agent cosalane have been synthesized and evaluated as inhibitors of HIV-1 integrase and protease, HIV-1 replication, HIV-1 and HIV-2 cytopathicity, HIV-1- and HIV-2-mediated syncytium formation, and cytopathicity of a variety of human pathogenic viruses. The congeners displayed enhanced potencies relative to cosalane itself as inhibitors of HIV-1 integrase and protease. The two most potent analogues against HIV-1 integrase displayed IC50 values of 2.2 mu M, while the three most potent compounds against HIV-1 protease had IC50 values in the 0.35-0.39 mu M range. In addition to its activity against HIV-1 and HIV-2 cytopathicity, cosalane inhibited the cytopathic effects of herpes simplex virus-1, herpes simplex virus-2, and human cytomegalovirus at concentrations that were well below the cytotoxic concentrations. Potentially useful antiviral activities were also revealed for some of the new cosalane congeners against influenza virus, Junin virus, and Tacaribe virus.